Postmastectomy radiotherapy has been assessed in Sweden

07

Aug 2019

In Sweden, the County Councils are grouped into six healthcare regions to facilitate cooperation and to maintain a high level of advanced medical care. One of them is Västra Götaland County Council with its Health Technology Assessment (HTA) Center, which aimed to work for continuous development of knowledge-based care in the region and ensure that healthcare is supported by science and evaluation. Also, it should follow up on the development of evidence-based healthcare nationally and internationally.

In June 2019, Västra Götaland HTA-Centre has published an HTA report for the impact of postmastectomy radiotherapy (PMRT) on complications and results of immediate breast reconstruction. The following conclusions were provided:

  • PMRT compared with no radiotherapy (RT) may result in a small decrease in patient satisfaction in breast cancer patients undergoing immediate breast reconstruction (IBR) (low certainty of the evidence)
  • PMRT compared with no RT probably results in a clinically significant increase of implant or tissue expander loss in breast cancer patients undergoing IBR (moderate certainty of the evidence)
  • PMRT compared with no RT may result in a substantial increase of re-operations in breast cancer patients undergoing IBR (low certainty of the evidence)
  • PMRT compared with no RT may result in a significantly increased capsular contracture rate in breast cancer patients undergoing IBR (low certainty of the evidence)

These findings are important when informing and advising mastectomy patients when discussing the method of reconstruction, especially when it is already known that the patient will undergo PMRT. Furthermore, these results suggest that IBR has to be used with caution when PMRT is anticipated. There is still a lack of high-quality studies that evaluate the impact of PMRT compared with no RT on the breast-related outcome of the immediate implant or tissue expander-based breast reconstruction after mastectomy.

See the full report in Swedish and English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

12

May 2021

The Agency for Health Technology Assessment of Andalusia Autonomous Community in Spain (AETSA) systematically evaluates healthcare technologies and provides decision-makers with critically review information about their efficacy, safety, and effectiveness. Currently, the AETSA is working on assessments of laser-induced heat therapy in epilepsy surgery, stereotactic radiation therapy for the treatment of refractory ventricular tachycardia, implantable Holter monitor with ILink Online technology for prolonged cardiac monitoring, and other topics.

Read more

10

May 2021

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 6462 of April 21, 2021, Tuscany Regional Healthcare has published assessments of six medical devices of various therapeutic areas, including devices for the treatment of vaginal prolapse, cardiovascular conditions, an implant for vocal cord rehabilitation, and a cerebral embolic protective device.

Read more

06

May 2021

The Treatment Council (Behandlingsråd) is a new model for assessing treatment methods and health technologies, expected to become fully operational during 2021. The first meeting of the Treatment Council is planned to be conducted in May 2021. On April 15, 2021, the method and process frameworks of the Treatment Council (Behandlingsråd) were sent for consultation to the parties who have previously submitted consultation responses regarding these documents.

Read more

04

May 2021

In April 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0176 and 0073 with changes to be implemented not later than August 01, 2021. Four new procedure codes related to men's health and breast surgery and one new companion diagnostic code were introduced.

Read more

30

Apr 2021

The National Institute for Health and Care Excellence (NICE) is currently developing health technology assessments concerning eHealth technologies in its Medical Technologies Guidance, Diagnostic Guidance, and Medtech Innovation Briefing programs. As of late April 2021, there are thirteen ongoing assessments.

Read more